Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131

Figure 1

The cytotoxic effects of ANT shRNA or hNIS radioiodine gene therapy in CT26/NF cells. (A) and (C) Representative flow cytometry data for propidium iodide and Annexin V staining are shown. (B) and (D) The Y axis indicates the relative cell death (%), which is the sum of the early apoptotic portion (AV+PI-), the intermediate apoptotic portion (AV+PI+), and the late apoptotic portion (AV-PI-). The treated cells were stained with propidium iodide and FITC-conjugated Annexin V and analyzed using flow cytometry. The data shown are the mean of triplicate experiments; the bars represent the mean ± SD.

Back to article page